Aptamer Group seals two significant deals worth £235,000
Life sciences firm Aptamer Group has announced two significant deals worth a combined £235,000.
The York based operator was launched on AIM in 2021 to maximise the potential of its Optimer binder technology in applications across life sciences and other industries. Its latest deal wins have seen it secure a contract valued at up to £175,000 with a top five pharmaceutical company, and a deal worth up to £60,000 with a global provider of specialty enzymes used widely throughout the life sciences sector.
As part of the first contract, Aptamer will develop Optimer
Recommend
North Wales operation of pharma giant Wockhardt secures £20m new facility to expand
2025/05/15
2025/05/15
Bentley 'disappointed' at GMB strike vote
2025/05/15
2025/05/15
Pharmaceutical manufacturer Pharmaron's Cramlington base set for investment despite losses
2025/05/15
2025/05/15
Robotics pioneer Wootzano to swap County Durham for Tyneside in new HQ move
2025/05/15
2025/05/15
Endless-owned meat firms Smithfield Murray and YPM join forces as Karnova to plan further acquisitions
2025/05/15
2025/05/15
North East manufacturers chalk up top output growth
2025/05/15
2025/05/15
Tumble dryer factory could close, putting 150 jobs at risk
2025/05/15
2025/05/15
Plastic parts manufacturer merges with 100-year-old firm
2025/05/15
2025/05/15
Designer eyewear maker Inspecs expects drop in performance
2025/05/15
2025/05/15
Aston Martin strikes new pay deal with union and staff
2025/05/15
2025/05/15
